October 11, 2022
Estimated Release Date: November 21, 2022
Application Receipt Date: February 9, 2023
PAR-21-237 - NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required)
National Institute of Neurological Disorders and Stroke (NINDS)
The National Institute of Neurological Disorders and Stroke intends to publish a Notice of Special Interest for applications proposing qualifying clinical trials to study epidural stimulation in spinal cord injury. This notice is only for applications submitted to PAR-21-237 NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required) Funding Opportunity Announcement.
This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
|Release Date:||October 11, 2022|
Estimated Publication Date of Notice of Special Interest (NOSI):
|November 15, 2022|
First Estimated Application Due Date:
|February 9, 2023|
Earliest Estimated Award Date:
Earliest Estimated Start Date:
See PAR-21-237 for Funding Information.
See PAR-21-237 for Eligible Organizations.
Linda Bambrick, Ph.D.
National Institute of Neurological Disorders and Stroke